GSK Investigational Site — Traverse City, Michigan

GSK Investigational Site is a clinical research site located in Traverse City, Michigan, United States 49684.

Crixeo Clinical Trials Trust Score: 20/100 (FAILING). This profile has not yet been claimed by the site owner.

GSK Investigational Site has participated in 12 clinical trials.

Therapeutic areas: Epilepsy, Epilepsy, Partial, Macular Degeneration.

Sponsors: GlaxoSmithKline, Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA).

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Traverse City

Browse all research sites in Michigan · View every site in Traverse City

• Northern Michigan Hospital
• Munson Medical Center
• Research Site
• Northern Michigan Neurology
• Medical Research Associates
• Munson Healthcare
• Grand Traverse Allergy
• Associated Retinal Consultants PC
• Associated Retinal Consultants, P.C.
• Vision Research Foundation
• Pfizer Investigational Site

Sponsor Feasibility Report

Trust Score: 20/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for GSK Investigational Site?

GSK Investigational Site has a Crixeo Trust Score of 20/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has GSK Investigational Site conducted?

GSK Investigational Site has 12 clinical trials on record. Their work covers Epilepsy, Epilepsy, Partial, Macular Degeneration.

Is GSK Investigational Site accredited by Crixeo Clinical Trials?

GSK Investigational Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about GSK Investigational Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.